GlassScriptPhysician profile
Marilyn J Perkowski
NPI 1205851490
$5,460.64
in general payments reported to CMS, 2019-2025
43 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,084 · 2022: $1,011 · 2023: $1,040 · 2024: $970 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,365.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $904.48 | 2021-2025 | |
| Pfizer INC. | $647.69 | 2021-2025 | |
| Novo Nordisk INC | $446.22 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $404.15 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $368.95 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.06 | 2021-2025 | Jardiance, Ofev |
| Astellas Pharma US INC | $232.57 | 2021-2024 | Veozah, Myrbetriq |
| Lilly USA, LLC | $231.83 | 2021-2025 | Jardiance, Kisunla, Mounjaro |
| Abbott Laboratories | $163.19 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $154.88 | 2021-2025 | Otezla, Repatha, Repatha |
| Otsuka America Pharmaceutical, INC. | $148.64 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $136.91 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $100.86 | 2021-2024 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $99.31 | 2021 | |
| Evoke Pharma, INC. | $94.38 | 2021-2025 | Gimoti |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Perkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.